Pharmaceuticals, Biotechnology and Life Sciences
Acquisition of U.S. Laboratory and Lung Nodule Malignancy Risk Test Finalized BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc., today announced that it has…
DUBLIN–(BUSINESS WIRE)–The “Innovations in Biomarker Analytics” report has been added to ResearchAndMarkets.com’s offering. This global research service provides extensive information…
NEW YORK–(BUSINESS WIRE)–$BMY–Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol-Myers Squibb”) announced today the extension of the expiration date of the offers to…
DUBLIN–(BUSINESS WIRE)–The “Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025” report has been added to ResearchAndMarkets.com’s…
Lowers 2019 Earnings Guidance PHOENIX–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the third quarter ended September…
Full Mirvetuximab Soravtansine Phase 3 FORWARD I and Initial Phase 1b FORWARD II Triplet Data Presented at ESMO Phase 3…
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results…
Hemlibra is launched for hemophilia A with inhibitors in Taiwan on 1 November 2019 TOKYO–(BUSINESS WIRE)–#antibody—Chugai Pharmaceutical Co., Ltd. (TOKYO:…
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its…
Foresite Labs supports creative entrepreneurs working to solve our greatest unmet medical needs SAN FRANCISCO & BOSTON–(BUSINESS WIRE)–Foresite Labs, LLC,…